In the Original Article entitled “Association of intrarenal blood flow with renal function and target organ damage in hypertensive patients with fibromuscular dysplasia: the ARCADIA-POL study” published in the April 2019 issue (Januszewicz M, Januszewicz A, Michałowska I, et al. Pol Arch Intern Med. 2019; 129 (4): 234–241). doi:10.20452/pamw.4479) Table 4 was omitted. The table was added on page 241 of the article, as below.

Table 4. Renal arteries with no fibromuscular dysplasia lesions, fibromuscular dysplasia and nonsignificant renal artery stenosis, fibromuscular dysplasia and significant renal artery stenosis
ParameterRenal arteries without FMD lesions (1) (n = 84)Renal arteries with FMD lesions without significant RAS (2) (n = 180)Renal arteries with FMD lesions and significant RAS (3) (n = 37) RASP value
ANOVA1 vs 21 vs 32 vs 3

Length of kidney, mm

112.4 (10.1)

108.4 (10.7)

107.4 (8.2)

0.05

0.09

0.14

1.00

Vmax, cm/s

116.0 (43.8)

151.7 (57.7)

314.8 (105.6)

<0.001

<0.001

<0.001

<0.001

RAR

1.18 (0.47)

1.89 (0.75)

4.19 (2.09)

<0.001

0.005

<0.001

<0.001

RRI

0.60 (0.06)

0.59 (0.07)

0.47 (0.09)

<0.001

0.50

<0.001

<0.001

AT

20.2 (7.6)

24.2 (12.2)

61.4 (32.0)

<0.001

0.16

<0.001

<0.001

PI

1.08 (0.18)

1.09 (0.19)

1.12 (0.22)

0.64

1.00

1.00

1.00

Data are presented as mean (SD).

Abbreviations: AT, acceleration time; PI, pulsatility index; RAR, renal aortic ratio; Vmax, maximal blood flow velocity; others, see Table 1

The article is correct at www.mp.pl/paim.